David S Kinard Elanco Animal Health Inc (ELAN) insider trading activity

David S Kinard is of Elanco Animal Health Inc. Currently has a direct ownership of 149,646 shares of ELAN, which is worth approximately $2.01 Million. The most recent transaction as insider was on Mar 01, 2024, when has been sold 5,731 shares (Common Stock) at a price of $16.03 per share, resulting in proceeds of $91,867. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 150K

0% 3M change

15.38% 12M change

Total Value Held $2.01 Million

David S Kinard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2024	SELL Payment of exercise price or tax liability	$91,867 $16.03 p/Share	5,731 Reduced 3.69%	149,646 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	15,596 Added 9.12%	155,377 Common Stock
Feb 27 2024	SELL Payment of exercise price or tax liability	$109,047 $16.46 p/Share	6,625 Reduced 4.53%	139,781 Common Stock
Feb 27 2024	BUY Grant, award, or other acquisition	-	14,562 Added 9.05%	146,406 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$136,733 $11.01 p/Share	12,419 Reduced 8.74%	129,693 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$11,109 $11.01 p/Share	1,009 Reduced 0.88%	113,541 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	28,571 Added 16.74%	142,112 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$27,947 $11.26 p/Share	2,482 Reduced 2.6%	92,860 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	22,270 Added 16.21%	115,130 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$25,346 $29.0 p/Share	874 Reduced 0.92%	94,643 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$49,893 $28.94 p/Share	1,724 Reduced 1.77%	95,517 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	8,665 Added 8.18%	97,241 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$244,212 $25.98 p/Share	9,400 Reduced 9.59%	88,576 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	-	22,598 Added 18.74%	97,976 Common Stock
Oct 20 2021	SELL Payment of exercise price or tax liability	$69,508 $33.66 p/Share	2,065 Reduced 2.67%	75,378 Common Stock
Mar 02 2021	SELL Payment of exercise price or tax liability	$18,531 $32.34 p/Share	573 Reduced 0.73%	77,443 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$16,253 $33.65 p/Share	483 Reduced 0.62%	78,016 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	6,717 Added 7.88%	78,499 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	$118,345 $30.58 p/Share	3,870 Reduced 5.12%	71,782 Common Stock
Feb 22 2021	BUY Grant, award, or other acquisition	-	13,540 Added 15.18%	75,652 Common Stock
Dec 31 2020	SELL Payment of exercise price or tax liability	$164,207 $30.67 p/Share	5,354 Reduced 7.94%	62,112 Common Stock

DSK

David S Kinard

Greenfield, IN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELAN shares.

Notify only if

Value

Insider Trading

Get notified when an Elanco Animal Health Inc insider buys or sells ELAN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Elanco Animal Health Inc

Track Activities on ELAN

Account